Jci_page_head_homepage_01 Jci_page_head_homepage_02
George A. Calin, Carlo M. Croce
Published in Volume 117, Issue 8
J Clin Invest. 2007; 117(8):2059–2066 doi:10.1172/JCI32577
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 4
Principles of miRNA-based gene therapy and in vivo inhibition of miRNA in cancer cells.

The major types of new miRNA drugs or manipulations toward the therapeutic goal of reverting the malignant phenotype are presented in conjunction with the main miRNA abnormalities found in human cancers. AMOs, anti-mRNA oligonucleotides; LNAs, locked nucleic acids.